Proposal for a multidimensional staging system for chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 99, Issue 12, 2005, Pages 1546-1554

  Celli, Bartolome R ^a   Calverley, Peter M A ^b   Rennard, Stephen I ^c   Wouters, Emiel F M ^d   Agusti, Alvar ^e   Anthonisen, Nicholas ^f   MacNee, William ^g   Jones, Paul ^h   Pride, Neil ⁱ   Rodriguez Roisin, Roberto ^j   Rossi, Andrea ^k   Wanner, Adam ^l  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^j HOSPITAL CLÍNIC   (Spain)

^k OSPEDALI RIUNITI   (Italy)

^l UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Body mass index; Chronic obstructive pulmonary disease; Dyspnea; Factor analysis; Forced expiratory volume; Staging system; Statistical

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL;

ADULT; AGED; ARTERIAL GAS; ARTICLE; BODY MASS; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CORRELATION ANALYSIS; COUGHING; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BRONCHI; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NUTRITIONAL STATUS; PRINCIPAL COMPONENT ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SLEEP DISORDERS; SMOKING; SPUTUM;

EID: 28044462017     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.03.019     Document Type: Article

References (36)

1. C.J. Murray A.D. Lopez Mortality by cause for eight regions of the world: Global Burden of Disease Study Lancet 349 1997 1269-1276
2. S.L. Murphy Deaths: Final data for 1998. National vital statistics reports vol. 48(11) 2000 National Center for Health Statistics Hyattsville, MD
3. B. Celli W. Mc Nee ATS/ERS standards for the diagnosis and treatment of COPD Eur Respir J 23 2004 932-946
4. N.M. Siafakas P. Vermeire N.B. Pride P. Paoletti J. Gibson P. Howard J.C. Yernault M. Decramer T. Higenbottam D.S. Postma J. Rees Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Eur Respir J 8 1995 1398-1420
5. British Thoracic Society Guidelines for the management of chronic obstructive pulmonary disease Thorax 52 1997 S1-S26
6. J.G. Hay P. Stone J. Carter S. Church A. Eyre-Brook M.G. Pearson A.A. Woodcock P.M. Calverley Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease Eur Respir J 5 1992 659-664
7. A.J. France R.J. Prescott W. Biernacki A.L. Muir W. MacNee Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax 43 1988 621-626
8. M. Decramer R. Gosselink T. Troosters M. Verschueren G. Evers Muscle weakness is related to utilization of health care resources in COPD patients Eur Respir J 10 1997 417-423
9. J.E. Hodgkin Prognosis in chronic obstructive pulmonary disease Clin Chest Med 11 1990 555-569
10. N. Anthonisen E. Wright J. Hodgkin Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14-20
11. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Nocturnal Oxygen Therapy Trial Group Ann Intern Med 93 1980 391-398
12. Intermittent Positive Pressure Breathing Trial Group Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: A clinical trial Ann Intern Med 99 1983 612-620
13. N.R. Anthonisen Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials Am Rev Respir Dis 133 1989 S95-S99
14. A.M. Schols J. Slangen L. Volovics E.F. Wouters Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791-1797
15. D.A. Gerardi L. Lovett M.L. Benoit-Connors J.Z. Reardon R.L. ZuWallack Variables related to increased mortality following out-patient pulmonary rehabilitation Eur Respir J 9 1996 431-435
16. C. Landbo E. Prescott P. Lange J. Vestbo T.P. Almdal Prognostic value of nutritional status in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 1856-1861
17. B.R. Celli C.G. Cote J.M. Marin C. Casanova M. Montes de Oca R.A. Mendez V. Pinto Plata H.J. Cabral The body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005-1012
18. T. Hajiro K. Nishimura M. Tsukino A. Ikeda H. Koyama T. Izumi Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 785-790
19. Medical Research Council Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party Lancet 1 1981 681-686
20. P.W. Jones F.H. Quirk C.M. Baveystock P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321-1327
21. J.C. Bestall E.A. Paul R. Garrod R. Garnham P.W. Jones J.A. Wedzicha Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581-586
22. K. Nishimura T. Izumi M. Tsukino T. Oga Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD Chest 121 2002 1434-1440
23. C.M. Roberts J.R. Bugler R. Melchor M.R. Hetzel S.G. Spiro Value of pulse oximetry in screening for long-term oxygen therapy requirement Eur Respir J 6 1993 559-562
24. American Thoracic Society Lung function testing: Selection of reference values and interpretative strategies Am Rev Respir Dis 144 1991 1202-1218
25. D.A. Mahler J.F. Donohue R.A. Barbee M.D. Goldman N.J. Gross M.E. Wisniewski S.W. Yancey B.A. Zakes K.A. Rickard W.H. Anderson Efficacy of salmeterol xinafoate in the treatment of COPD Chest 115 1999 957-965
26. S.I. Rennard W. Anderson W.R. Zu J. Broughton W. Bailey M. Friedman M. Wisniewski K. Rickard Use of a long-acting inhaled beta(2)-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 1087-1092
27. R.J. Butland J. Pang E.R. Gross A.A. Woodcock D.M. Geddes Two-, six-, and 12-min walking tests in respiratory disease Br Med J (Clin Res Ed) 284 1982 1607-1608
28. D.A. Mahler D.H. Weinberg C.K. Wells A.R. Feinstein The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751-758
29. B.F.J. Manly Multivariate statistical methods: A primer 1986 Chapman & Hall London, New York
30. B. Burrows Predictors of loss of lung function and mortality in obstructive lung diseases Eur Respir Rev 1 1991 340-345
31. P.S. Burge P.M. Calverley P.W. Jones S. Spencer J.A. Anderson T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial Br Med J 320 2000 1297-1303
32. S. Spencer P.M. Calverley P. Sherwood Burge P.W. Jones Health status deterioration in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 122-128
33. A.L. Ries R.M. Kaplan E. Blumberg Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease J Clin Epidemiol 44 1991 497-503
34. D.A. Mahler K. Faryniarz D. Tomlinson G.L. Colice A.G. Robins E.M. Olmstead G.T. O'Connor Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease Chest 102 1992 395-401
35. R.E. Wegner R.A. Jorres D.K. Kirsten H. Magnussen Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD Eur Respir J 7 1994 725-729
36. E.F. Hansen K. Phanareth L.C. Laursen A. Kok-Jensen A. Dirksen Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 159 1999 1267-1271